All the news Showing 10 of 875 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Hepatitis C elimination 12 good practices that should be part of the hepatitis C standard of care Keith Alcorn / 25 March 2021 Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with hepatitis C, and update service models to improve hepatitis C elimination ... Hepatocellular carcinoma (HCC) Pancreatic and colorectal cancer risk raised in people with hepatitis C Keith Alcorn / 16 March 2021 Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer was more likely to occur in people diagnosed with hepatitis ... HBV treatment for people with HIV People with HIV and hepatitis B should have ongoing monitoring for liver cancer Liz Highleyman / 15 March 2021 People with HIV and hepatitis B co-infection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment and should undergo regular monitoring for liver cancer, according to research presented ... Coronavirus COVID-19 slows viral hepatitis elimination, global survey finds Keith Alcorn / 22 February 2021 COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ... Coronavirus Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Diabetes & HCV Hepatitis C treatment reduces stroke and heart attack risk Keith Alcorn / 18 February 2021 Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the Journal of Viral Hepatitis shows. People with hepatitis C ... Injecting drug use Hepatitis C declining among drug users in UK Keith Alcorn / 11 February 2021 The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ... Adherence to treatment High adherence and hepatitis C cure rates in active drug and alcohol users Keith Alcorn / 04 February 2021 People who use drugs achieved high rates of hepatitis C cure on direct-acting antiviral treatment despite ongoing drug and alcohol use, demonstrating that active drug use should not be a barrier to ... Hepatitis C elimination Hepatitis C elimination in France feasible if new infections in gay and bisexual men decline Keith Alcorn / 27 January 2021 Hepatitis C is becoming more concentrated in gay and bisexual men with HIV in France as direct-acting antiviral treatment cures the infection in other people with HIV while hepatitis C transmission between ... Fibrosis HIV doubles the risk of liver fibrosis by middle-age, without viral hepatitis Michael Carter / 26 January 2021 Having HIV almost doubles the risk of liver fibrosis, according to European research published in the online edition of the Journal of Infectious Diseases. Investigators in Denmark and the Netherlands ... ← Prev1...23456...88Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds